The following is general information about the COVID-19 Vaccine, Booster and Pediatric Vaccine

Individuals 18 years of age or older may receive either the Pfizer-BioNTech, Moderna, Novavax or Johnson & Johnson vaccines.
Pfizer-BioNTech and Moderna vaccines are available for children ages 6 months to 17 years of age.
Novavax is available for children ages 12 to 17 years of age.

Pfizer-BioNTech
For patients 18 years and older:
Pfizer-BioNTech is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.

For patients ages 6 months to 4 years of age:
Pfizer-BioNTech is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Updated Pfizer-BioNTech booster is available and can be administered at least 8 weeks after the second primary dose.

For patients ages 5 to 11 years of age:
Pfizer-BioNTech is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.
Children 5 years of age can only receive the Pfizer-BioNTech booster.
Children aged 6 to 11 years of age can receive the Pfizer-BioNTech or Moderna booster.

For patients ages 12 to 17 years of age:
Pfizer-BioNTech is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.

Novavax
For patients 18 years and older:
Novavax is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.
Novavax booster is available in limited situations.

For patients ages 12 to 17 years of age:
Novavax is 2 doses for primary administration. The 2nd dose following 3-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.

Moderna
For patients 18 years and older:
Moderna is 2 doses for primary administration. The 2nd dose following 4-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.

For patients ages 6 months to 5 years of age:
Moderna is 2 doses for primary administration. The 2nd dose following 4-8 weeks after the primary administration.
Updated Moderna booster is available and can be administered at least 2 months after the second primary dose.
Children ages 6 months to 4 years can only receive the Moderna booster.
Children ages 5 years of age can receive the Pfizer-BioNTech or the Moderna booster.

For patients ages 6 to 17 years of age:
Moderna is 2 doses for primary administration. The 2nd dose following 4-8 weeks after the primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary dose or last booster.

Janssen(J&J)
For patients 18 years and older:
J&J is 1 for dose primary administration.
Moderna or Pfizer-BioNTech updated booster may be give at least 2 months after the 2nd primary does.

More information booster shots may be found here.
CDC (Center for Disease Control) Staying up to date
CDC (Center for Disease Control) Booter Information

FDA (U.S. Food and Drug Administration) Booster Information.

Information about the use of the Pfizer vaccine in Children ages 5-11 years of age may be found here:
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age

Updated: 4/25/2023